
MHE October 2023



Laws since 1996 have sought to assure that coverage of behavioral health treatments does not take a back seat to physical medicine. Amid a national crisis in mental illness and addiction, that new world of equality has not arrived. But is it on the way?

Two drugs that target the c-MET protein are in phase 3 trials.

Payers and hospitals are at odds over proposals that would level out payments to hospital outpatient departments and physician offices.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Eylea HD Provides Vision Gains and Longer Dosing Intervals in Real-World Analysis | AAO 2025
2
What’s New in the Diagnosis and Treatment of Headaches That Ophthalmologists Should Know About? | AAO 2025
3
Making Sense of the Eye Pain-Headache Connection | AAO 2025
4
AI in Ophthalmology: The Key to the Present Success Includes a CPT Code. The Future? Agentic AI That Doesn’t Wait To Be Told What To Do | AAO 2025
5